The Venter Lab retweeted
In spite of the global crisis of #AMR, another pharmaceutical company abandons antibacterial drug development. We need alternative models to fund such programs and support for researchers at academic institutions working on anti-bacterials.
Johnson & Johnson stops development of all antibacterial programs. Sigh!
J&J developed Levaquin, bedaquiline, and several other life-saving antibiotics.
Obviously this happens because they can't make money on antibiotics. Thi…lnkd.in/eSQgfX-t lnkd.in/eK-3RuP4
The Venter Lab retweeted
#Antibiotic R&D pipeline remains insufficient to tackle the growing spread of #AntibioticResistance & #access to treatments is still a challenge...😔
Latest @WHO report highlighting the progress but also the remaining gaps 👇
who.int/news/item/15-05-2023…
#PowerOfAntibiotics
The Venter Lab retweeted
Antibiotic-resistant infections caused 5 million deaths in 2019. In 2020, hospital-onset #AMR infections and deaths jumped 15%. In 2023, superbug outbreaks have gripped our attention. The time to act is now @CentreImpactAMR @WHO workingtofightamr.org/2023/0…
The Venter Lab retweeted
It was a great opportunity to present our work on #AMR in #AgedCare at the #AMRSummitSA today and to meet and talk to so many interested in combating AMR.
Thank you @nadinehillock for the lovely photos.
Keynote speaker at the SA One Health AMR summit Assoc Prof Rietie Venter presenting her research team’s work investigating AMR in aged care facilities … high rates of MDR E. coli in RACFs without stewardship programs #AMRsummitSA #AMR #AgedCare @LabMuis #wastewater #OneHealth
The Venter Lab retweeted
Replying to @LabVenter
@LabVenter look at how biocides contribute to the development of #AMR. New PhD student Owen will work on the formulation of responsible cleaning products with a lower risk for #AMR development. Huge thanks to @DIIS_SA, @MTPConnect_AUS, @UniversitySA, @sachiefsci and Hygiene Co.
The Venter Lab retweeted
I am so glad I came to BacPath and given this opportunity to share my work. It’s been fantastic talking to people who loves bacteria 😄
Session 6 // featured five brilliant ECR and MCR talks on antibiotic resistance and novel approaches to combat MDR infections #AMR #acinetobacterbaumannii #Cdiff #staphylococcus #chryseobacterium by @DrDe_Oliveira; Yogi Srikhanta @LyrasLab; Winton Wu; @JhihHang & @ann_hahahah
The Venter Lab retweeted
#MicrobeoftheMonth! Can you guess who I am?
1) I have a sweet, grape-like aroma.
2) Most of the time, I don't cause problems—but I can infect everything from the blood to the lungs.
3) I'm known for my sticky biofilms.
Leave a guess below & stay tuned for the big reveal!
The Venter Lab retweeted
This is evolution on steroids!
Scientists found a colistin resistance gene in Pseudomonas that mutate 1000x faster than other genes.
#AMR #Pseudomonas
Localized pmrB hypermutation drives the evolution of colistin heteroresistance cell.com/cell-reports/fullte…
The Venter Lab retweeted
Antimicrobial-resistant infections killed an estimated 4·95 million people in 2019. This is a silent pandemic, one that does not attract much attention or research money. #AMR
The overlooked pandemic of antimicrobial resistance thelancet.com/journals/lance…
The Venter Lab retweeted
Taking AIM-1 at carbapenem resistance in Pseudomonas aeruginosa. A potent resistance gene 'jumped' from a harmless environmental organism to this dangerous pathogen. Read more:
unisa.edu.au/media-centre/Re…
Or read our manuscript: microbiologyresearch.org/con… #AMR @MicrobioSoc
The Venter Lab retweeted
Covid-19 affected antimicrobial prescribing with decreases in dispensing of 22%-49% for several antimicrobials in Australia. Good news from @ACSQHC and an opportunity to obtain a sustainable reduction in inappropriate prescribing. #Antimicrobial resistance
The Venter Lab retweeted
Open access publishing did well in the latest altmetrics. Significant increases in impact factors for journals we contribute to: @FrontMicrobiol, @antibioticsmdpi and portlandpress.com/bioscirep from @PPPublishing. Less papers and more robust reviewing can work for #OpenAccess.
The Venter Lab retweeted
📢Editor Choice Article:
Evaluation of #Benzguinols as Next-Generation #Antibiotics for the Treatment of #Multidrug-#Resistant #Bacterial #Infections by Dr. Abiodun D. Ogunniyi et al. from @UniofAdelaide
👉mdpi.com/2079-6382/10/6/727
#Staphylococcus #pseudintermedius


















